AGP Executive Report
Last update: 5 hours agoCancer Research & Drug Development: GSK’s licensor Hansoh Pharma says its B7-H3-targeted antibody-drug conjugate Ris-Rez (risvutatug rezetecan) hit the main goal in a China Phase 3 trial for advanced/relapsed small-cell lung cancer, improving overall survival versus topotecan, with no new safety concerns—data now set to support a China regulatory submission. Public Health Preparedness: Macau’s Centre for Disease Prevention and Control has joined the WHO Global Outbreak Alert and Response Network (GOARN), aiming to boost disease surveillance, risk assessment, and outbreak response links with global partners. Heat & Worker Safety: Macau’s observatory issued a Yellow hot weather alert, with temperatures expected up to around 35°C, while DSAL urged heatstroke prevention for outdoor workers, including cooling vests and more site inspections. Community Health Support: Sands China assembled 5,000 “food kits” with nutritionist-designed recipe cards and Health Bureau guidance, supporting the Healthy Community push. Caregiving & Ageing: The Social Welfare Bureau plans a pilot support centre for carers in the northern district, offering caregiving skills training, emotional support, and follow-up services. Macau Health System Spotlight: Macau Union Hospital reported performing the city’s first robotic-assisted partial knee replacement, underscoring growing local medical capability.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
